MYDGF may promote tumor angiogenesis and macrophage infiltration in hepatocellular carcinoma, releasing inflammatory cytokines, including IL-6 and TNF-α, which accelerate tumor progression (52). Here, IL6 is linked to hepatocellular carcinoma.